Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combined Antibody Screening for Celiac and Diabetes Evaluation

NCT04677699 is registered in ClinicalTrials.gov with Pacific Northwest Research Institute as lead sponsor.

NCT NCT04677699
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04677699 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combined Antibody Screening for Celiac and Diabetes Evaluation
Lead sponsor
Pacific Northwest Research Institute
Phase
Observational
Overall status
Unknown status
Start date
December 31, 2020
Completion date
June 30, 2026
Enrollment
64,410 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

celiac disease, type 1 diabetes